Page last updated: 2024-12-11
1-alpha, 25-difluorovitamin d3
1-alpha, 25-dihydroxyvitamin D3, also known as **calcitriol**, is the **active form of vitamin D** in the body. It plays a crucial role in **calcium and phosphorus metabolism**, which are essential for maintaining bone health, muscle function, and overall health.
**Here's why it's important for research:**
* **Bone Health:** Calcitriol promotes calcium absorption in the gut and helps maintain bone density. Research on calcitriol focuses on understanding its role in preventing and treating osteoporosis, rickets, and other bone diseases.
* **Immune Function:** Calcitriol has been shown to modulate immune responses and may be involved in regulating autoimmune diseases. Research is exploring its potential therapeutic applications in inflammatory conditions.
* **Cancer Prevention:** Some studies suggest that calcitriol may have anti-cancer properties and may help prevent the development of certain types of cancer. This area of research is still ongoing.
* **Cardiovascular Health:** Calcitriol may play a role in regulating blood pressure and reducing the risk of cardiovascular disease. Research is exploring its potential benefits in preventing heart attacks and strokes.
* **Mental Health:** Emerging research indicates that calcitriol may be linked to mood regulation and could have implications for treating depression and other mental health conditions.
**Research on calcitriol is vital for:**
* **Understanding the complex mechanisms** by which it regulates various bodily functions.
* **Developing new therapies** to treat diseases associated with vitamin D deficiency, such as osteoporosis, rickets, and some autoimmune disorders.
* **Investigating its potential role** in the prevention and treatment of other diseases, such as cancer and cardiovascular disease.
**Key points about calcitriol research:**
* **It is a rapidly evolving field** with new discoveries constantly being made.
* **Ethical considerations** are important, as high doses of calcitriol can have adverse effects.
* **Further research** is needed to fully understand its role in human health and to develop safe and effective therapies.
Cross-References
ID Source | ID |
PubMed CID | 6444057 |
MeSH ID | M0098373 |
Synonyms (4)
Synonym |
1-alpha, 25-difluorovitamin d3 |
(1s,3z,5r)-3-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-6-fluoro-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol |
9,10-secocholesta-5,7,10(19)-trien-3-ol, 1,25-difluoro-, (1alpha,3beta,5z,7e)- |
78609-64-0 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.01
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.01 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.80 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |